<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-114279</identifier>
<setSpec>1887-8571</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Use of blood components, medications and procedures for the hemorrhage treatment in the military environment</dc:title>
<dc:description xml:lang="en">The bleeding control is one of the topics in military medicine. Hemorrhagic shock is the leading cause of preventable  death in combat and is a challenge in medical logistics. The objective of this study is to analyze the concept and physiopathology of  the hemorrhage, describing blood components (packed red blood cells, platelets, whole blood, blood components and frozen blood  components), medications (fibrinogen, prothrombin complex, recombinant activated factor VII and tranexamic acid) and procedures (tactical hemorrhage control, damage control surgery, damage control resuscitation and thromboelastometry) that can be employed to control bleeding in the military environment (AU)</dc:description>
<dc:creator>Povo Castilla, J</dc:creator>
<dc:creator>Álvarez Herranz, P</dc:creator>
<dc:creator>Navarro Suay, R</dc:creator>
<dc:creator>Hernández Abadía de Barbará, A</dc:creator>
<dc:creator>de Prádena y Lobón, J. M</dc:creator>
<dc:creator>Sáenz Casco, L</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">El control de la hemorragia es uno de los pilares de la medicina militar. El shock hemorrágico es la primera causa tratable de muerte  en combate y supone un reto dentro de la logística sanitaria. El objetivo de este estudio es analizar el concepto y fisiopatología de la  hemorragia, describir los componentes sanguíneos (concentrado de hematíes, plaquetas, sangre completa, plasmaféresis y componentes sanguíneos congelados), fármacos (fibrinógeno, complejo protrombínico, factor VII activado recombinante y ácido tranexámico) y procedimientos (control de la hemorragia a nivel táctico, cirugía del control del daño, resucitación del control del daño y  tromboelastometría) que se pueden emplear para el control de la hemorragia en ambiente militar (AU)</dc:description>
<dc:source>Sanid. mil;69(2): 87-94, jun. 2013. tab</dc:source>
<dc:identifier>ibc-114279</dc:identifier>
<dc:title xml:lang="es">Empleo de componentes sanguíneos, fármacos  y procedimientos para el tratamiento de la hemorragia  en ambiente militar</dc:title>
<dc:subject>^d29611</dc:subject>
<dc:subject>^d29510^s22074</dc:subject>
<dc:subject>^d6622^s22067</dc:subject>
<dc:subject>^d34735</dc:subject>
<dc:subject>^d13149^s22067</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d30229^s22074</dc:subject>
<dc:subject>^d14540^s22073</dc:subject>
<dc:subject>^d22179^s22073</dc:subject>
<dc:subject>^d51708</dc:subject>
<dc:subject>^d35135</dc:subject>
<dc:subject>^d24643^s22073</dc:subject>
<dc:type>article</dc:type>
<dc:date>201306</dc:date>
</metadata>
</record>
</ibecs-document>
